Used primarily in scientific research as a key intermediate in the development of pharmaceutical agents targeting central nervous system disorders. Shows potential in the study of dopamine and serotonin receptor modulation, making it relevant in the exploration of antipsychotic and antidepressant drugs. Its structure supports binding affinity to specific neural receptors, aiding in the design of novel neuroactive compounds. Also employed in structure-activity relationship (SAR) studies to optimize pharmacological properties in quinazoline-based therapeutics. Not intended for diagnostic or therapeutic use in humans.